AstraZeneca Signs Massive US$8.5 B Oncology Collaboration with Merck & Co Following Trial Failure |
Abstract
pdf
html
|
Daniel Roberts & Natasha Piper |
|
Bristol-Myers Squibb Fights Immuno-oncology Competition with Early stage Biotech Acquisition |
Abstract
pdf
html
|
Natasha Piper |
|
Mitsubishi Pharma Acquires NeuroDerm for Parkinson’s Drug |
Abstract
pdf
html
|
Jawala Prasad |
|
Gilead Acquires CAR-T Oncology Specialist Kite for US$11.9 B |
Abstract
pdf
html
|
Daniel Roberts |
|
IMS PharmaDeals: Half-Year Review of 2017 |
Abstract
pdf
|
Heather Cartwright & Taskin Ahmed |
|